SCHEMBL13626345

SCHEMBL13626345

O=C(CCl)N1CC2CCCC(CC2)C1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.50
LMNA P02545 1/20 0.50
SMN1; SMN2 Q16637 3/20 0.36
POLB P06746 1/20 0.36
HTT P42858 1/20 0.36
CHRNB2 P17787 2/20 0.35
CHRNA3 P32297 2/20 0.35
CHRNA4 P43681 2/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA7 P36544 1/20 0.35
YAP1 P46937 1/20 0.34
TEAD4 Q15561 1/20 0.34
JAK2 O60674 1/20 0.33
MITF O75030 1/20 0.33
CHRNB3 Q05901 1/20 0.31
CHRNA6 Q15825 1/20 0.31
GPX4 P36969 1/20 0.30
SMYD3 Q9H7B4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL224873 0.94 ALDH1A1 (0.52) ALDH1A1LMNASMN1; SMN2POLBHTT
SCHEMBL4436959 0.81 ALDH1A1 (0.52) ALDH1A1LMNASMN1; SMN2POLBHTT
SCHEMBL4446700 0.81 ALDH1A1 (0.52) ALDH1A1LMNASMN1; SMN2POLBHTT
SCHEMBL16082804 0.73
SCHEMBL24694729 0.71 ALDH1A1 (0.47) ALDH1A1LMNASMN1; SMN2POLBHTT
SCHEMBL16490225 0.71 CHRNB2 (0.62) ALDH1A1LMNAPOLBCHRNB2CHRNA3
SCHEMBL16083079 0.71
SCHEMBL7543479 0.71 CHRNB2 (0.38) ALDH1A1LMNACHRNB2CHRNA3CHRNA4
SCHEMBL11836780 0.71 ALDH1A1 (0.57) ALDH1A1LMNASMN1; SMN2POLBHTT
SCHEMBL15336652 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612114-B2 Such as (R)-6-{2-{ethyl[4-(2-ethylaminoethyl)benzyl]amino }-4-methoxyphenyl }-5,6,7,8-tetrahydronaphthalen-2-ol; osteoporosis; breast cancer EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-11-03 US disclosed